Article
Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.
Molecular pharmaceutics - 1 Apr 2013
Davis James R, Mossalam Mohanad, Lim Carol S
Abstract excerpt
The tumor suppressor p53 can be sent to the proteasome for degradation by placing its nucleo-cytoplasmic shuttling under ligand control. Endogenous p53 is ubiquitinated by MDM2 in the nucleus, and controlling the access of p53 to the nuclear compartment regulates its ubiquitination and proteasomal degradation. This was accomplished by the use of a protein switch that places nuclear translocation under the control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
